206 related articles for article (PubMed ID: 24014053)
1. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
Fu HL; Shao L; Wang Q; Jia T; Li M; Yang DP
Tumour Biol; 2013 Dec; 34(6):3817-21. PubMed ID: 24014053
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
Wu J; Guo A; Li Q; Wang D
Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
5. Comment on Fu et al.: A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
Chen J; Ma L; Wei G
Tumour Biol; 2014 May; 35(5):5049-50. PubMed ID: 24363085
[No Abstract] [Full Text] [Related]
6. Circular RNA circ-NT5C2 acts as a potential novel biomarker for prognosis of osteosarcoma.
Nie WB; Zhao LM; Guo R; Wang MX; Ye FG
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6239-6244. PubMed ID: 30338784
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
[TBL] [Abstract][Full Text] [Related]
8. TP53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data.
Chen Z; Guo J; Zhang K; Guo Y
Dis Markers; 2016; 2016():4639575. PubMed ID: 27239089
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis.
Jiang L; Tao C; He A
Tumour Biol; 2013 Apr; 34(2):1037-43. PubMed ID: 23341181
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated circRNAs serve as prognostic and diagnostic markers in osteosarcoma by sponging microRNA to regulate the downstream signaling pathway.
Huang X; Yang W; Zhang Z; Shao Z
J Cell Biochem; 2020 Feb; 121(2):1834-1841. PubMed ID: 31642106
[TBL] [Abstract][Full Text] [Related]
11. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
13. Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.
Serra M; Maurici D; Scotlandi K; Barbanti-Brodano G; Manara MC; Benini S; Picci P; Bertoni F; Bacci G; Sottili S; Baldini N
Int J Oncol; 1999 Feb; 14(2):301-7. PubMed ID: 9917506
[TBL] [Abstract][Full Text] [Related]
14. Expression of molecular markers in the tumor and survival prognosis in osteosarcoma.
Boulytcheva IV; Soloviev YN; Kushlinskii NE; Mahson AN
Bull Exp Biol Med; 2010 Dec; 150(2):237-42. PubMed ID: 21240382
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis.
Guo S; Bai R; Zhao W; Wang Y; Zhao Z; Feng W
Tumour Biol; 2014 Jan; 35(1):469-73. PubMed ID: 23959472
[TBL] [Abstract][Full Text] [Related]
16. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
Li RZ; Wang LM
World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
[TBL] [Abstract][Full Text] [Related]
17. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
18. Expressions of p53, c-MYC, BCL-2 and apoptotic index in human osteosarcoma and their correlations with prognosis of patients.
Wu X; Cai ZD; Lou LM; Zhu YB
Cancer Epidemiol; 2012 Apr; 36(2):212-6. PubMed ID: 21890444
[TBL] [Abstract][Full Text] [Related]
19. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
20. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]